Tuberculosis Drugs Market Size Share Trends Forecast 2026

1. TUBERCULOSIS DRUGS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Tuberculosis Drugs Market - Overview Tuberculosis Drugs Market, by Therapy Type (First Line Therapy, and Second Line Therapy), by Disease type (Active TB, and Latent TB), by End User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2019 – 2027 Global Tuberculosis Drugs Market, by Therapy Type (First Line Therapy, and Second Line Therapy), by Disease type (Active TB, and Latent TB), by End User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 1,146.5 million in 2019, and is expected to exhibit a CAGR of 5.3% over the forecast period (2019 - 2027). Increasing funding and expenditure on TB treatment and research is driving growth of the market. For instance, according to the WHO, the global TB-related funding to 119 emerging economies reached around US$ 6.9 billion in 2018, from US$ 3.3 billion in 2006, where 86% of the total funding is provided by Brazil, Russia, India, China, and South Africa (BRICS). Advanced technologies and introduction of novel therapies are expected to improve the duration of treating TB, however, most TB cases with currently available medicines can require up to 6 months of treatment. There is continuous need to improve patients’ access to appropriate TB medicines particularly in the areas of multidrug-resistant TB (MDR TB) and pediatric TB. Browse Research Reports: https://www.coherentmarketinsights.com/market- insight/tuberculosis-drugs-market-191 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Furthermore, increasing research and drug development activities are driving growth of the market. For instance, in 2019, the U.S. FDA approved the TB Alliance manufactured drug Pretomanid for the treatment of a specific type of highly treatment-resistant tuberculosis (TB) of the lungs. Additionally, the tuberculosis drugs market size is expected to witness significant growth, owing to increasing global incidence of TB. For instance, according to the WHO Global Tuberculosis Report 2018, it’s estimated that around 10 million people suffered from TB disease in 2017, which included 5.8 million men, 3.2 million women, and 1.0 million children. Key players operating in this market are adopting collaboration strategies to meet the increasing demand of TB treatment drugs. For instance, in 2015, Dishman Pharmaceuticals and Chemicals Limited entered into license collaboration with Johnson & Johnson to manufacture raw material for drugs used in the treatment of multi drug resistant tuberculosis (MDR-TB). Browse 33 Market Data Tables and 28 Figures spread through 198 Pages and in-depth TOC on "Tuberculosis Drugs Market, by Therapy Type (First Line Therapy, and Second Line Therapy), by Disease type (Active TB, and Latent TB), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Global Forecast to 2027“ Tuberculosis (TB) is a chronic condition, and has become a global disease burden. Manufacturers of TB drugs are focused on developing drugs that can shorten the duration of treatment, and help to overcome challenges of drug-susceptible TB and drug-resistant TB. The treatment of TB is divided into two types, such as first line treatment, second line treatment, and drug resistant treatment. Request a Sample copy of this reports : https://www.coherentmarketinsights.com/insight/request-sample/191 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Key Takeaways of the Tuberculosis Drugs Market: The global tuberculosis drugs market is projected to exhibit a CAGR of 5.3% over the forecast period (2019–2027), owing to increasing prevalence of TB in emerging economies. According to the WHO report 2018, the Asia Pacific and Africa accounted for about 70% of overall global TB cases. Moreover, in 2017, the high-incidence countries were located in these two regions. Among region, Asia Pacific is expected to witness growth in the global tuberculosis drugs market over the forecast period, owing to high burden TB in major countries such as China, India, Japan, and Australia among others. For instance, according to the WHO, in 2016, about 2.79 million people suffered from TB in India. Among therapy, first line therapy segment held the dominant position in TB drugs market during forecasted year, owing to increasing usage of first line drugs in TB treatment which have lesser side effects compared to second line therapy drugs Major players operating in the global tuberculosis drugs market include Johnson & Johnson Services, LLC, Lupin ltd., Novartis AG, Macleods Pharmaceuticals Ltd., Otsuka Pharmaceutical Co., Ltd., Pfizer Inc., and others. Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/191 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved